drugset / Trial / NCT02182882

Efficacy of Ginsana in Improving Half-time Hemoglobin Re-oxygenation in Healthy People

NCT02182882 ↗

Phase 2 Completed 29 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

Study to assess the efficacy of ginsana in improving half-time hemoglobin re-oxygenation in healthy, recreational sportspeople and to assess the safety of the product

Timeline

Start
1999-03
Primary completion
1999-10
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject GINSANA Unknown — —

Indications

No indication recorded.